Status:

UNKNOWN

VRQOL in Cataract Patients During the COVID-19 Pandemic

Lead Sponsor:

Medical University Innsbruck

Conditions:

Senile Cataract

Eligibility:

All Genders

50+ years

Brief Summary

The aim of this questionnaire survey is to evaluate the improvement in vision-related quality of life before and after cataract surgery using the National Eye Institute Visual Function Questionnaire 2...

Eligibility Criteria

Inclusion

  • Age ≥ 50 years
  • Senile cataract
  • Indication for unilateral or bilateral cataract surgery
  • Postponed cataract surgery due to the COVID-19 pandemic
  • Signed and dated declaration of consent

Exclusion

  • Complex form of cataract (traumatic cataract, secondary cataract after intraocular inflammation)
  • Amblyopia on the eye that is to be operated on
  • Severe, visually impairing eye disease on the eye that is to operated on
  • Known dementia or memory problems

Key Trial Info

Start Date :

September 8 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 1 2021

Estimated Enrollment :

116 Patients enrolled

Trial Details

Trial ID

NCT04468308

Start Date

September 8 2020

End Date

March 1 2021

Last Update

September 23 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical University Innsbruck

Innsbruck, Tyrol, Austria, 6020